Literature DB >> 25037694

Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity.

Wen-Chin Tsai1, Ting-I Lee2, Yao-Chang Chen3, Yu-Hsun Kao4, Yen-Yu Lu5, Yung-Kuo Lin6, Shih-Ann Chen7, Yi-Jen Chen8.   

Abstract

BACKGROUND: Aging and testosterone deficiency contribute to the pathogenesis of atrial fibrillation (AF). We determine the effects of testosterone replacement on the electrophysiology and arrhythmogenesis of pulmonary vein (PV) and left atrium (LA) in aged rabbits.
METHODS: Electrocardiography, heart rate variability, echocardiography, Western blot and conventional microelectrodes were used in aged rabbits (age, >2 years) with and without (control) testosterone treatment (10mg/kg, 12 weeks).
RESULTS: Testosterone-treated aged rabbits had longer corrected QT interval, higher low frequency/high frequency, greater left ventricle (LV) mass but lower LA total emptying fraction and LV ejection fraction than control rabbits. In tissue preparations, the spontaneous rate was faster for testosterone-treated PVs than for control PVs. Angiotensin II concentration-dependently increased the amplitude of delayed afterdepolarizations (DADs) in testosterone-treated PVs but only did so at the highest angiotensin II concentration (100 nM) in control PVs. Isoproterenol increased the incidence of early afterdepolarizations (EADs) and DADs in testosterone-treated PVs but not in control PVs. Testosterone-treated PVs had more H2O2-induced burst firing and EADs than control PVs. Testosterone-treated LAs had more isoproterenol-induced DADs and spontaneous activity than did control LAs. However, acetylcholine infusion and rapid atrial pacing (10-20 Hz) induced AF in control LAs but not in testosterone-treated LAs. In addition, as compared with control LAs, testosterone-treated LAs expressed more androgen receptor, β1-adrenergic receptor, and Cav 1.2 and less G protein-coupled receptor kinase-2 and Kv 4.2.
CONCLUSIONS: Testosterone replacement increased arrhythmogenesis in PV and LA by enhancing adrenergic activity in aged rabbits.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adrenergic activity; Atrial fibrillation; Pulmonary vein; Testosterone

Mesh:

Substances:

Year:  2014        PMID: 25037694     DOI: 10.1016/j.ijcard.2014.06.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Revealing the Influences of Sex Hormones and Sex Differences in Atrial Fibrillation and Vascular Cognitive Impairment.

Authors:  Ya-Ting Chang; Yung-Lung Chen; Hong-Yo Kang
Journal:  Int J Mol Sci       Date:  2021-08-16       Impact factor: 6.208

2.  Central and peripheral testosterone effects in men with heart failure: An approach for cardiovascular research.

Authors:  Željko Bušić; Viktor Čulić
Journal:  World J Cardiol       Date:  2015-09-26

3.  Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome.

Authors:  Deniz Akdis; Ardan M Saguner; Khooshbu Shah; Chuanyu Wei; Argelia Medeiros-Domingo; Arnold von Eckardstein; Thomas F Lüscher; Corinna Brunckhorst; H S Vincent Chen; Firat Duru
Journal:  Eur Heart J       Date:  2017-05-14       Impact factor: 29.983

4.  Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation.

Authors:  Rishi Sharma; Olurinde A Oni; Kamal Gupta; Mukut Sharma; Ram Sharma; Vikas Singh; Deepak Parashara; Surineni Kamalakar; Buddhadeb Dawn; Guoqing Chen; John A Ambrose; Rajat S Barua
Journal:  J Am Heart Assoc       Date:  2017-05-09       Impact factor: 5.501

Review 5.  Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias.

Authors:  Virginie Grouthier; Melissa Y Y Moey; Estelle Gandjbakhch; Xavier Waintraub; Christian Funck-Brentano; Anne Bachelot; Joe-Elie Salem
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

6.  The relationship between serum sex hormone and cardiac echocardiographic findings in healthy men.

Authors:  Sang-Chol Lee; Yun-Mi Song; Yohwan Yeo; Seung Woo Park
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

7.  Connexin Lateralization Contributes to Male Susceptibility to Atrial Fibrillation.

Authors:  Simon Thibault; Anh-Tuan Ton; François Huynh; Céline Fiset
Journal:  Int J Mol Sci       Date:  2022-09-14       Impact factor: 6.208

8.  Ventricular Tachyarrhythmia Risk in Paediatric/Young vs. Adult Brugada Syndrome Patients: A Territory-Wide Study.

Authors:  Sharen Lee; Wing Tak Wong; Ian Chi Kei Wong; Chloe Mak; Ngai Shing Mok; Tong Liu; Gary Tse
Journal:  Front Cardiovasc Med       Date:  2021-06-11

9.  Plasma testosterone and arrhythmic events in male patients with arrhythmogenic right ventricular cardiomyopathy.

Authors:  Jie Ren; Liang Chen; Ningning Zhang; Xiao Chen; Qian Zhao; Kai Chen; Xiangjie Li; Frank Ruschitzka; Firat Duru; Jiangping Song
Journal:  ESC Heart Fail       Date:  2020-05-29

Review 10.  Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of in vitro and in vivo Models.

Authors:  Giorgia Beffagna; Elena Sommariva; Milena Bellin
Journal:  Front Physiol       Date:  2020-11-12       Impact factor: 4.755

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.